News
Cancer cells decorate themselves with the CD47 protein, signaling the immune system to stand down. Whitehead Institute Valhalla Fellow Kipp Weiskopf and colleagues have developed a novel drug screen, pinpointing which cancer therapies — when combined with CD47-blocking antibodies — fare best at rallying the immune system against lung cancer cells.
As part of the Whitehead Institute Board of Directors’ strategy for continuing renewal, three highly regarded Board members will leave those roles this July. Each has made significant contributions to the organization’s ongoing capacity to conduct cutting-edge biomedical research and to train future scientific leaders.
Axolotls (Ambystoma mexicanum) are a critically endangered species of salamander. They are also highly regenerative. The latest story in our Unusual Labmates series explores these fascinating creatures, what Whitehead Institute researchers are hoping to discover by studying them, and why they are worth preserving in the wild. Click here to view the full multimedia story.
Whitehead Institute researchers are making discoveries that are helping us rethink what we know about the brain and paving the way for therapies to treat some of the most challenging brain disorders and diseases.
Researchers at Whitehead Institute are breathing new life into the study of rejuvenation, the ability of cells to repair and replenish tissues — and potentially learning how to slow or reverse the changes our cells experience over time.
Whitehead Institute is dedicated to training the next generation of scientists, especially postdocs. Get to know a few of these remarkable scientists through these profiles.
Whitehead Institute scientists work to combat climate change.
